SGLT2 inhibitors modulate arterial stiffness and cardiovascular disease risk in patients with diabetes mellitus.
Absolute Event Rate: 0% vs 0%
Bentham Science - STM publisher of online and print journals, and related print/online book series. Bentham Science answers the information needs of scientists in the fields of pharmaceutical, biomedical, medical, engineering, technology, computer and social sciences.
Olga Lamacchia (Fri,) reported a other. SGLT2 inhibitors modulate arterial stiffness and cardiovascular disease risk in patients with diabetes mellitus.